Drug Shortages Information Center

The availability of needed medications has become a serious concern across the entire health care system, including ASCs.

The Food and Drug Administration (FDA) is responsible for coordinating federal responses to drug shortages, and according to NIH, the number of drugs in short supply has more than tripled since 2006. In 2012, Congress passed legislation called the "Food and Drug Administration Safety and Innovation Act." This bill seeks to mitigate the drug shortage problem and has been credited with slowing the number of drugs added to the shortage list. When the FDA is notified of a potential shortage, they work with the pharmaceutical industry and other stakeholders to respond.

If your facility is having problems obtaining needed medications, please take the following actions:

  • Email the FDA. The agency will need the following information: the name and dosage of the medication in question, and your geographic location.

  • For Consumer Complaints (and suspected price gouging), contact the Federal Trade Commission (FTA) Consumer Response Center:

Online: Use the online complaint form

Phone: Toll-free 877.FTC.HELP (382.4357); 9:00 am to 8:00 pm (EST), Monday through Friday

Mail: Consumer Response Center, Federal Trade Commission, 600 Pennsylvania Ave, NW, Washington, DC 20580

The FDA needs the above information to determine the severity of the problem. Additionally, ASCA is closely monitoring the issue. If you suspect a shortage, please e-mail Kristin Murphy. To access the drug shortage database, click here.

The American Society of Health Systems Pharmacists provides information on drugs in short supply, as well as potential substitutions. It is recommended consulting with the appropriate personnel/board(s) at your facility in regards to utilizing substitutions.

Online Resources

FDA: Drug Shortages Information Page

FDA: Current Drug Shortages Database

American Society of Health-System Pharmacists (ASHP) Drug Shortage Database

ASHP Guidance on IV Bag Conservation

FDA: Guidance for the industry